Page 37 - Read Online

Bergara-Muguruza et al. J Transl Genet Genom 2023;7:213-229 https://dx.doi.org/10.20517/jtgg.2023.14 Page 229

83. Bao MH, Feng X, Zhang YW, Lou XY, Cheng YU, Zhou HH. Let-7 in cardiovascular diseases, heart development and
cardiovascular differentiation from stem cells. Int J Mol Sci 2013;14:23086-102. DOI PubMed PMC
84. Kong Y, Hsieh CH, Alonso LC. ANRIL: a lncRNA at the CDKN2A/B locus with roles in cancer and metabolic disease. Front
Endocrinol 2018;9:405. DOI PubMed PMC
85. Chi JS, Li JZ, Jia JJ, Zhang T, Liu XM, Yi L. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. J
Huazhong Univ Sci Technolog Med Sci 2017;37:816-22. DOI PubMed
86. Zhao W, Smith JA, Mao G, et al. The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region. BMC
Med Genomics 2015;8:21. DOI PubMed PMC
87. Rankin CR, Shao L, Elliott J, et al. The IBD-associated long noncoding RNA IFNG-AS1 regulates the balance between inflammatory
and anti-inflammatory cytokine production after T-cell stimulation. Am J Physiol Gastrointest Liver Physiol 2020;318:34-40. DOI
PubMed PMC
88. Padua D, Mahurkar-Joshi S, Ka XI, et al. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer
of inflammation. Am J Physiol Gastrointest Liver Physiol 2016;311:446-57. DOI PubMed PMC
89. Vigneau S, Rohrlich PS, Brahic M, Bureau JF. Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be
implicated in the regulation of gamma interferon. J Virol 2003;77:5632-8. DOI PubMed PMC
90. Petermann F, Pękowska A, Johnson CA, et al. The magnitude of IFN-γ responses is fine-tuned by DNA architecture and the non-
coding transcript of ifng-as1. Mol Cell 2019;75:1229-42.e5. DOI PubMed PMC
91. Gomez JA, Wapinski OL, Yang YW, et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the
interferon-γ locus. Cell 2013;152:743-54. DOI PubMed PMC
92. McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 2017;389:2328-37. DOI PubMed
93. Terao C, Raychaudhuri S, Gregersen PK. Recent advances in defining the genetic basis of rheumatoid arthritis. Annu Rev Genomics
Hum Genet 2016;17:273-301. DOI PubMed PMC
94. Yang J, Li Z, Wang L, et al. The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis.
Pharmacol Res 2022;186:106549. DOI
95. Zhang Z, Zhang W, Wen QW, et al. Associations of genetic polymorphisms within MALAT1, UCA1, FAM211A-AS1 and
AC000111.6 with genetic susceptibility to rheumatoid arthritis. Autoimmunity 2020;53:408-14. DOI
96. Pan F, Zhu L, Lv H, Pei C. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating
lncRNA MALAT1. Int J Mol Med 2016;38:1507-14. DOI PubMed
97. Yan ZF, Zhao XY, Liu W, Liu XP. UCA1 impacts progress of rheumatoid arthritis by inducing the apoptosis of fibroblast-like
synoviocyte. Eur Rev Med Pharmacol Sci 2018;22:914-20. DOI PubMed
98. Yuan M, Wang S, Yu L, et al. Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease
activity in PBMCs from patients with rheumatoid arthritis. PLoS One 2017;12:e0186795. DOI PubMed PMC
99. Zhang Y, Xu YZ, Sun N, et al. Long noncoding RNA expression profile in fibroblast-like synoviocytes from patients with
rheumatoid arthritis. Arthritis Res Ther 2016;18:227. DOI PubMed PMC
100. Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased
survival in systemic lupus erythematosus. Ann Rheum Dis 2020;79:363-9. DOI PubMed PMC
101. Zhao CN, Mao YM, Liu LN, Li XM, Wang DG, Pan HF. Emerging role of lncRNAs in systemic lupus erythematosus. Biomed
Pharmacother 2018;106:584-92. DOI PubMed
102. Hao H, Nakayamada S, Ohkubo N, et al. Involvement of lncRNA IL21-AS1 in interleukin-2 and T follicular regulatory cell
activation in systemic lupus erythematosus. Arthritis Res Ther 2021;23:302. DOI PubMed PMC
103. Hao H, Nakayamada S, Yamagata K, et al. Conversion of T follicular helper cells to T follicular regulatory cells by interleukin-2
through transcriptional regulation in systemic lupus erythematosus. Arthritis Rheumatol 2021;73:132-42. DOI
104. Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009;27:363-91. DOI
PubMed PMC
105. Mercer TR, Munro T, Mattick JS. The potential of long noncoding RNA therapies. Trends Pharmacol Sci 2022;43:269-80. DOI
PubMed
106. Lee JS, Mendell JT. Antisense-mediated transcript knockdown triggers premature transcription termination. Mol Cell 2020;77:1044-
54.e3. DOI PubMed PMC
107. Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med 2018;24:257-77.
DOI PubMed PMC
108. Shi Y, Parag S, Patel R, et al. Stabilization of lncRNA GAS5 by a small molecule and its implications in diabetic adipocytes. Cell
Chem Biol 2019;26:319-30.e6. DOI PubMed PMC
109. Abulwerdi FA, Xu W, Ageeli AA, et al. Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA,
MALAT1. ACS Chem Biol 2019;14:223-35. DOI PubMed PMC
110. Aguilo F, Di Cecilia S, Walsh MJ. Long non-coding RNA ANRIL and polycomb in human cancers and cardiovascular disease. Curr
Top Microbiol Immunol 2016;394:29-39. DOI PubMed PMC